- Home
- NXTC vs CNEY Comparison
NXTC vs CNEY Comparison
Compare NXTC & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- CNEY
- Stock Information
- Founded
- NXTC 2015
- CNEY 2018
- Country
- NXTC United States
- CNEY China
- Employees
- NXTC N/A
- CNEY N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- CNEY Major Chemicals
- Sector
- NXTC Health Care
- CNEY Industrials
- Exchange
- NXTC Nasdaq
- CNEY Nasdaq
- Market Cap
- NXTC 13.0M
- CNEY 12.4M
- IPO Year
- NXTC 2019
- CNEY 2021
- Fundamental
- Price
- NXTC N/A
- CNEY $2.32
- Analyst Decision
- NXTC Strong Buy
- CNEY
- Analyst Count
- NXTC 2
- CNEY 0
- Target Price
- NXTC $25.50
- CNEY N/A
- AVG Volume (30 Days)
- NXTC 10.5K
- CNEY 53.0K
- Earning Date
- NXTC 11-06-2025
- CNEY 01-01-0001
- Dividend Yield
- NXTC N/A
- CNEY N/A
- EPS Growth
- NXTC N/A
- CNEY N/A
- EPS
- NXTC N/A
- CNEY N/A
- Revenue
- NXTC N/A
- CNEY $36,049,275.00
- Revenue This Year
- NXTC N/A
- CNEY N/A
- Revenue Next Year
- NXTC N/A
- CNEY N/A
- P/E Ratio
- NXTC N/A
- CNEY N/A
- Revenue Growth
- NXTC N/A
- CNEY N/A
- 52 Week Low
- NXTC $2.69
- CNEY $1.56
- 52 Week High
- NXTC $19.20
- CNEY $21.61
- Technical
- Relative Strength Index (RSI)
- NXTC N/A
- CNEY 44.36
- Support Level
- NXTC N/A
- CNEY $2.18
- Resistance Level
- NXTC N/A
- CNEY $2.95
- Average True Range (ATR)
- NXTC 0.00
- CNEY 0.19
- MACD
- NXTC 0.00
- CNEY -0.02
- Stochastic Oscillator
- NXTC 0.00
- CNEY 5.94
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.